CTRI/2018/05/013775招募中未知
A PROSPECTIVE, COMPARATIVE, RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SNEC30 (CURCUMA LONGA) CAPSULES IN THE TREATMENT OF TYPE 2 DIABETES
Arbro Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1 Subject or his legally accepted representative is willing to give informed consent
- •2 Patients of either sex between the age group 18 to 65 years (both inclusive)
- •3 Suffering from diabetes type 2 ( between 1 to 10 years)
- •4 Patients with diabetes who administer oral hypoglycemic agents
- •5 Patients with HbA1c between 7.0-9.5 %.
排除标准
- •1 Patients suffering from any of the following conditions will be excluded from the study:
- •a Type 1 diabetes mellitus
- •b Patients with severe hyperglycemia (FBS >234 mg% or PPBS > 360 mg%)
- •c Patients with fasting serum cholesterol >260mg% and serum Triglycerides >300 mg%.
- •d Patients with HbA1c more than 9.5 %.
- •e Patients with AST and ALT levels greater than
- •2 5 times the upper normal limits
- •f Severe renal, hepatic or respiratory disorder.
- •g Patients with psychiatric disorder.
- •h Patients with haematological disorders
- •I History of smoking (more than 10 cigarettes/day) or alcohol intake > 20 gm/day.
- •j Complications of diabetes such as;
- •Proliferative type retinopathy
- •Nephropathy with laboratory values greater than 1.5 times the upper normal limits
- •Presence of ketone bodies in urine analysis
- •Ischemic heart disease with any cardiac event in last 6 months
- •Fasting serum cholesterol >260mg. % and serum Triglycerides >300 mg%.
- •2 Patients with BMI >35 kg/m2
- •3 Patients who are likely to undergo surgery during the study period.
- •4 Patients who have participated in any investigational study in the last 4 weeks.
- •5 Patients having known hypersensitivity to the study drugs.
- •6 Patients with any severe infection
- •7 Patients with a history of intake of ANY Ayurveda/herbal/homeopathic/dietary supplements (including Vitamin E) or any alternative therapies in the last one month
- •9 Pregnant or lactating females and women in child bearing age refusing to use contraceptives.
研究者
相似试验
招募中
不适用
A PROSPECTIVE, COMPARATIVE, RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SNEC30 (CURCUMA LONGA) CAPSULES AND SNEC ORAL GEL TOPICAL APPLICATION IN THE TREATMENT OF ORAL SUBMUCOSAL FIBROSISCTRI/2018/02/011939Arbro Pharmaceuticals Pvt Ltd
尚未招募
不适用
COMPARITIVE STUDY BETWEEN DEXMEDETOMEDINE AND BUPRENORPHINE AS AN ADJUVANT TO ROPIVACAINE 0.5% IN ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB ORTHOPEDIC SURGERIESCTRI/2021/10/037274Sanjay Gandhi Institute Of Trauma And Orthopedics
已完成
不适用
Comparing one day of intravenous Amikacin to 3 days in preventing urinary infection in patients undergoing transurethral resection of the ProstateCTRI/2017/09/009721Fluid research fund CMC Vellore338
已完成
不适用
A Randamized, Prospective and Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucomaveitic GlaucomaJPRN-UMIN000007820Deportment of Ophthalmology, University of Tokyo Hospital120
已完成
不适用
A PROSPECTIVE RANDOMIZED COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF THREE DIFFERENT SURGICAL PROCEDURES FOR CONJUNCTIVOCHALASISJPRN-UMIN000011170Toko Dental College Ichikawa General Hospital60